2009-10-12
Product Name: Foscarnet Sodium
CAS# 63585-09-1
Standard: Not less than 99.0%
Impurity D: not...
Foscarnet Sodium
|
2009-10-12
Daptomycin
Formula: C72H101N17O26
Mol. Wet: 1620.67
CAS#: 103060-53-3
Quality Standard:...
Daptomycin
|
2009-10-12
Pimecrolimus
CAS:137071-32-0
Pimecrolimus is a new topical steroid-free medication with...
Pimecrolimus
|
2009-10-12
English name: Acitretin
Synonyms: aromatic Victoria A acid; atracurium Ting
CAS NO.: 55079-83-9...
Acitretin
|
|
|
2009-10-12
Name: Mizolastine
CAS #: 108612-45-9
Appearance: White or almost white powder
Assay: 99%....
Mizolastine
|
2009-10-12
Name：Clemastine Fumarate
Structure: C21H26ClNO•C4H4O4
Formula Weight: 459.97
Appearance: White...
Clemastine Fumarate
|
|
|
2009-10-12
Oxiconazole nitrate
CAS No: 64211-46-7
Name: Oxiconazole nitrate
Synonyms: (Z)-1-(2-(2,...
Oxiconazole nitrate
|
2009-10-12
Ketotifen Fumarate
M.F: C19H19NOS.C4H4O4
MW: 425.49
CAS: 34580-14-8
Apprearance: white...
Ketotifen Fumarate
|
2009-10-12
Adapalene
Therapeutic category: Dermatological, a Topical Treatment for Acne
CAS NO.:...
Adapalene
|
2009-10-12
Name：Oxatomide
Molecular Formula C27H30N4O
Molecular Weight 426.55
CAS Registry Number...
Oxatomide
|
2009-10-12
Name: Fusidate Acid
CAS #: 751-94-0
Appearance: while crystalline power
Assay: ≥98% (TLC)....
Fusidate Acid
|
2009-10-12
Amorolfine hydrochloride
Molecular Formula: C21H36ClNO
Molecular Structure:
Molecular Weight:...
Amorolfine hydrochloride
|
|
|
|
|
|
|
2009-10-11
flap weight width price
650/700-16 0.9kg 160mm USD 0.68
750/825-16 1.1kg 175mm USD...
flaps, tyre flap , otr flap
|
2009-10-11
flap weight width price
650/700-16 0.9kg 160mm USD 0.68
750/825-16 1.1kg 175mm USD...
flaps, tyre flap , otr flap
|
|
|
|
|
|
|
2009-10-11
flap weight width price
650/700-16 0.9kg 160mm USD 0.68
750/825-16 1.1kg 175mm USD...
flap, car flap , otr flap
|
|
|
|
|
|
|
|
|
|
|
|
|
2009-10-11
flap weight width price
650/700-16 0.9kg 160mm USD 0.68
750/825-16 1.1kg 175mm USD...
flaps, flap , tyre flap
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|